The Quantellect read.As of Nov 19, 2026, 3 active firms cover biote Corp: 2 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $1.50 to $4.00 (about 2.7x), a sign of real disagreement on valuation. The average target of $2.50 sits 183% above the current $0.88. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.04 next quarter toward $0.24 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy267%
Neutral133%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$2.50
+182.9% upside
Average target across 3 active firms as of Nov 19, 2026 vs $0.88 current
Highest Target$4.00
Average Target$2.50
Lowest Target$1.50
Detailed analyst forecasts for BTMD
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 2 of 3 active firms rate BTMD a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BTMD EPS & revenue forecast
EPS · NEXT QUARTER
$0.04
Range $0.01 – $0.08 · 2 analysts · -43% YoY
Next period, 2 analysts expect biote Corp to earn $0.04 a share (range $0.01 – $0.08), versus $0.08 a year earlier. Full-year consensus is $0.06, growing to $0.24 the year after.
REVENUE · NEXT QUARTER
$43.8M
Range $41.7M – $45.0M · 2 analysts · -3% YoY
Revenue is expected to reach $43.8M (range $41.7M – $45.0M), -2.6% year-over-year. Full-year consensus is $176.1M, rising to $181.2M next year.
Top analysts covering biote Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BTMD.
#1
Jeff Van Sinderen
B. Riley Securities · Rank #118
Neutral
$1.50+69.8% to target
Overall win rate
42%
+ Follow
#2
JK
Jonna Kim
TD Cowen
Buy
$2.00+126.3% to target
Coverage
—
+ Follow
#3
AF
Alex Fuhrman
Craig-Hallum
Buy
$8.00+805.4% to target
Coverage
—
+ Follow
#4
GF
Gregory Fraser
Truist Securities
Buy
$4.00+352.7% to target
Coverage
—
+ Follow
#5
Kaumil Gajrawala
Jefferies
Buy
$5.92+570.0% to target
Coverage
—
+ Follow
BTMD stock forecast FAQ
What is BTMD's average 12-month price target?+
The 3 active firms with a live target average $2.50 for biote Corp over the next 12 months, ranging from a $4.00 high to a $1.50 low, as of Nov 19, 2026.
Is BTMD stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BTMD?+
The Street-high target is $4.00 (Truist Securities), and the Street-low is $1.50 (B. Riley Securities). The average of all 3 active-firm targets is $2.50.
How many active Wall Street firms cover BTMD?+
3 active firms have a recognized rating on biote Corp as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BTMD?+
Among analysts who currently cover BTMD, Jeff Van Sinderen of B. Riley Securities has the strongest overall Quantellect track record (Rank #118). Their current call is Neutral with a $1.50 target.
What is biote Corp's projected EPS for next quarter?+
The consensus estimate is $0.04 per share (range $0.01 – $0.08) across 2 analysts. Full-year EPS is projected at $0.06, rising to $0.24 the following year.
How much revenue is biote Corp expected to report next quarter?+
Consensus revenue is $43.8M (range $41.7M – $45.0M). Full-year revenue is projected at $176.1M, growing to $181.2M next year.
Have analysts been upgrading or downgrading BTMD lately?+
As of Nov 19, 2026, 2 of 3 active firms rate BTMD a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BTMD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.